Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Nausea × Aprepitant × Clear all

Phase

Status

Completed 20 Unknown 5 Terminated 2 Withdrawn 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Vomiting 1 Nausea 1 Lymphoma, Non-Hodgkin 1 Lymphoma 1

Interventions

Ondansetron 2 casopitant 1 Vincristine 1 Tropisetron 1 Therapeutics 1 Rituximab 1 R-CHOP protocol 1 Psychiatric Rehabilitation 1 Prochlorperazine 1 Prednisolone 1 Palonosetron 1 Midazolam 1 Metoclopramide 1 Lorazepam 1 Granisetron 1 Exercise 1 Doxorubicin 1 Dexmedetomidine 1 Dexamethasone 1 Cyclophosphamide 1 Aprepitant 1 Antiemetics 1 Acupuncture Points 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01843868 2024-08-07

Emesis Control Study in Non-Hodgkin Lymphoma Patients Receiving R-CHOP

Australasian Leukaemia and Lymphoma Group

Phase NA Withdrawn

Lymphoma, Lymphoma, Non-Hodgkin, Nausea, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon ⚡